LISA Catheter With Marked vs. Unmarked Tip in Extremely Low Birth Weight Infants With RDS
Primary Purpose
Respiratory Distress Syndrome, Newborn
Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Surfactant administration with less invasive surfactant administration (LISA) marked tip catheter
Surfactant administration with less invasive surfactant administration (LISA) unmarked tip catheter
Sponsored by
About this trial
This is an interventional treatment trial for Respiratory Distress Syndrome, Newborn
Eligibility Criteria
Inclusion Criteria:
- Level III NICU consultants and residents will be eligible to participate in the study
Exclusion Criteria:
- Refusal to participate in the study.
Sites / Locations
- Daniele Trevisanuto
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Surfactant administration with less invasive surfactant administration (LISA) marked tip catheter
Surfactant administration with less invasive surfactant administration (LISA) unmarked tip catheter
Arm Description
Participants will be assigned to perform the procedure with a LISA catheter with a marked tip
Participants will be assigned to perform the procedure with a LISA catheter with an unmarked tip
Outcomes
Primary Outcome Measures
Number of participants who will achieve the positioning of the device at the correct depth in the trachea
Number of participants who will achieve the positioning of the device at the correct depth in the trachea (as assessed by the external observer using a laryngoscope).
Secondary Outcome Measures
Time for positioning the device in the trachea
The time of device positioning will be defined as the time elapsed from the positioning of the laryngoscope in the manikin mouth to the connection of the syringe to the catheter
Number of attempts for positioning the device in the trachea
The total number of attempts for positioning the device in the trachea
Participant opinion on using the device
Participant opinion on using the device which will be evaluated using a Likert scale (1 worse outcome to 5 best outcome)
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05399628
Brief Title
LISA Catheter With Marked vs. Unmarked Tip in Extremely Low Birth Weight Infants With RDS
Official Title
LISA Catheter With Marked vs. Unmarked Tip in Extremely Low Birth Weight Infants With RDS: a Crossover Randomized Controlled Manikin Trial
Study Type
Interventional
2. Study Status
Record Verification Date
July 2022
Overall Recruitment Status
Completed
Study Start Date
June 6, 2022 (Actual)
Primary Completion Date
June 11, 2022 (Actual)
Study Completion Date
June 11, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital Padova
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
This is an unblinded, randomized, controlled, crossover (AB/BA) trial of surfactant treatment with LISA catheter with a marked tip vs. LISA catheter with an unmarked tip in a manikin simulating an extremely low birth weight infant. Participants will be level III NICU consultants and residents. Randomization will be performed using a computer-generated random assignment list. The primary outcome measure will be the positioning of the device at the correct depth in the trachea. The secondary outcome measures will be the time and number of attempts to achieve the correct depth and participant satisfaction.
Detailed Description
Although less invasive surfactant administration (LISA) offers some advantages in ventilation procedure and neonatal outcomes, achieving the correct depth in the trachea using a LISA catheter may be difficult. This may have some drawbacks such as impaired surfactant administration (reducing the efficacy of the procedure) or prolonged duration of the laryngoscopy (aggravating the invasiveness of the procedure).
The aims of the present study should be: i) positioning of the device at the correct depth in the trachea, ii) time and number of attempts to achieve the correct depth, iii) participant satisfaction.
This is an unblinded, randomized, controlled, crossover (AB/BA) trial of surfactant treatment with LISA catheter with a marked tip vs. LISA catheter with an unmarked tip in a manikin simulating an extremely low birth weight infant. Participants will be level III NICU consultants and residents. Randomization will be performed using a computer-generated random assignment list. The primary outcome measure will be the positioning of the device at the correct depth in the trachea. The secondary outcome measures will be the time and number of attempts to achieve the correct depth and participant satisfaction.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Distress Syndrome, Newborn
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Participants in AB arm will be assigned to perform the procedure with LISA catheter with marked tip, followed by the procedure with LISA catheter with unmarked tip. Participants in BA arm will be assigned to the reverse sequence. A washout period of 6 hours (one procedure in the morning and one in the afternoon) will be included to reduce any carryover effect
Masking
None (Open Label)
Masking Description
Due to the characteristics of the intervention, both participants and outcome assessors cannot be masked. The statistician will be blind to the intervention arms.
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Surfactant administration with less invasive surfactant administration (LISA) marked tip catheter
Arm Type
Experimental
Arm Description
Participants will be assigned to perform the procedure with a LISA catheter with a marked tip
Arm Title
Surfactant administration with less invasive surfactant administration (LISA) unmarked tip catheter
Arm Type
Active Comparator
Arm Description
Participants will be assigned to perform the procedure with a LISA catheter with an unmarked tip
Intervention Type
Device
Intervention Name(s)
Surfactant administration with less invasive surfactant administration (LISA) marked tip catheter
Intervention Description
Participants will be assigned to perform the procedure with LISA catheter with a marked tip
Intervention Type
Device
Intervention Name(s)
Surfactant administration with less invasive surfactant administration (LISA) unmarked tip catheter
Intervention Description
Participants will be assigned to perform the procedure with LISA catheter with an unmarked tip
Primary Outcome Measure Information:
Title
Number of participants who will achieve the positioning of the device at the correct depth in the trachea
Description
Number of participants who will achieve the positioning of the device at the correct depth in the trachea (as assessed by the external observer using a laryngoscope).
Time Frame
5 minutes
Secondary Outcome Measure Information:
Title
Time for positioning the device in the trachea
Description
The time of device positioning will be defined as the time elapsed from the positioning of the laryngoscope in the manikin mouth to the connection of the syringe to the catheter
Time Frame
5 minutes
Title
Number of attempts for positioning the device in the trachea
Description
The total number of attempts for positioning the device in the trachea
Time Frame
5 minutes
Title
Participant opinion on using the device
Description
Participant opinion on using the device which will be evaluated using a Likert scale (1 worse outcome to 5 best outcome)
Time Frame
10 minutes
10. Eligibility
Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Level III NICU consultants and residents will be eligible to participate in the study
Exclusion Criteria:
Refusal to participate in the study.
Facility Information:
Facility Name
Daniele Trevisanuto
City
Padova
ZIP/Postal Code
35128
Country
Italy
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
The data will be available upon motivated request to the corresponding author
Citations:
PubMed Identifier
30974433
Citation
Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A, Plavka R, Roehr CC, Saugstad OD, Simeoni U, Speer CP, Vento M, Visser GHA, Halliday HL. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update. Neonatology. 2019;115(4):432-450. doi: 10.1159/000499361. Epub 2019 Apr 11.
Results Reference
background
Learn more about this trial
LISA Catheter With Marked vs. Unmarked Tip in Extremely Low Birth Weight Infants With RDS
We'll reach out to this number within 24 hrs